Press release
Retinal Disorders Treatment Market Outlook 2030: From US$ 9.18 Billion in 2022 to US$ 19 Billion by 2030, Driven by Aging Population and Therapeutic Advancements
Retinal Disorders Treatment Market
To Get Sample Report Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=79712
Market Overview
The Retinal Disorders Treatment Market includes therapies (anti-VEGF, corticosteroids, gene therapies), devices (laser systems, vitrectomy machines), and diagnostics for conditions like AMD and diabetic retinopathy. Valued at US$ 9.18 billion in 2022, it is expected to reach US$ 19 billion by 2030 at a CAGR of 7%. The market is segmented by treatment type (anti-VEGF, corticosteroids, gene therapy, others), indication (AMD, diabetic retinopathy, retinal vein occlusion, others), end-user (hospitals, ophthalmology clinics, ambulatory surgical centers), distribution channel (hospital pharmacies, retail pharmacies, online), and region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa). Anti-VEGF therapies, like ranibizumab, dominate due to their efficacy, while ophthalmology clinics lead as end-users.
Key Drivers of Growth
Several factors are propelling the Retinal Disorders Treatment Market:
Aging Population: The global elderly population, projected to reach 1.4 billion by 2030, increases AMD prevalence, driving demand for treatments.
Rising Diabetes Prevalence: Over 537 million adults with diabetes in 2021 (IDF) contribute to diabetic retinopathy cases, boosting market growth.
Therapeutic Advancements: Innovations like biosimilars (e.g., ranibizumab biosimilars) and gene therapies (e.g., Luxturna) improve outcomes, fueling adoption.
Increasing Healthcare Investments: Expanded access to ophthalmology services in emerging markets supports market expansion.
Awareness and Screening Programs: Initiatives like WHO's Vision 2020 enhance early diagnosis, increasing treatment demand.
Top Companies:
Allergan plc
Bayer AG, F.
Hoffmann-La Roche Ltd.
Graybug Vision, Inc.
Kubota Pharmaceutical Holdings Co., Ltd.
Novartis AG, Pfizer, Inc.
Regeneron Pharmaceuticals, Inc.
Santen Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Company Limited
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/retinal-disorders-treatment-market.html
Challenges and Barriers
Despite its growth potential, the market faces several challenges:
High Treatment Costs: Anti-VEGF therapies, costing $10,000-$20,000 annually, limit accessibility in low-income regions.
Limited Access in Developing Regions: Inadequate ophthalmology infrastructure in Africa and parts of Asia-Pacific restricts market penetration.
Regulatory Complexities: Stringent approval processes for gene therapies and biologics increase costs and delay market entry.
Side Effects: Risks like intraocular inflammation from anti-VEGF injections may reduce patient compliance.
Shortage of Specialists: Limited availability of retinal specialists in rural areas hinders timely treatment delivery.
Regional Insights
The Retinal Disorders Treatment Market exhibits distinct regional dynamics:
North America: Dominates with a significant share in 2022, driven by high AMD prevalence, advanced healthcare, and key players like Regeneron. The U.S. leads due to robust adoption of anti-VEGF therapies.
Europe: Holds a substantial share, with Germany, France, and the UK benefiting from aging populations and strong healthcare systems.
Asia-Pacific: Fastest-growing region, fueled by rising diabetes prevalence, increasing healthcare access, and investments in China, India, and Japan.
Latin America: Moderate growth, with Brazil and Mexico leading due to improving ophthalmology infrastructure. Cost barriers limit adoption.
Middle East & Africa: Smallest share due to limited healthcare facilities. Growth opportunities exist in Gulf countries with rising investments.
Future Opportunities
The Retinal Disorders Treatment Market offers several avenues for growth and innovation:
Gene and Cell Therapies: Expanding research into therapies like RGX-314 for AMD could address unmet needs and drive market growth.
Biosimilar Adoption: Cost-effective biosimilars for drugs like ranibizumab can improve accessibility in emerging markets.
AI-Driven Diagnostics: AI-powered imaging tools for early retinal disease detection could enhance treatment outcomes.
Expansion in Emerging Markets: Increasing healthcare investments in Asia-Pacific and Latin America present opportunities for affordable therapies.
Teleophthalmology: Remote consultation platforms can improve access to retinal care in underserved areas.
Browse More Trending Research Reports:
Liquid Filled Hard Capsules Market: https://www.globenewswire.com/news-release/2023/7/4/2699010/0/en/Liquid-Filled-Hard-Capsules-Market-to-Grow-at-a-CAGR-of-7-8-from-2022-to-2031-reaching-US-4-0-billion-As-per-TMR-Study.html
Oral Rehydration Solution [ORS] Market: https://www.globenewswire.com/news-release/2023/10/05/2755222/32656/en/Oral-Rehydration-Solution-ORS-Market-to-Exceed-USD-6-71-billion-by-2031-Capturing-a-9-9-CAGR-TMR-Report.html
Atopic Dermatitis Drugs Market: https://www.globenewswire.com/news-release/2023/07/31/2715115/32656/en/Atopic-Dermatitis-Drugs-Market-to-Grow-at-a-CAGR-of-14-7-from-2022-to-2031-reaching-USD-29-4-Billion-As-per-TMR-Study.html
Oligonucleotides Market: https://www.globenewswire.com/news-release/2024/12/02/2989923/32656/en/Oligonucleotides-Market-Outlook-2034-Projected-to-Reach-US-13-1-Billion-by-2034-Driven-by-Expanding-Applications-in-Biotechnology-and-Precision-Medicine-TMR.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Retinal Disorders Treatment Market Outlook 2030: From US$ 9.18 Billion in 2022 to US$ 19 Billion by 2030, Driven by Aging Population and Therapeutic Advancements here
News-ID: 4101291 • Views: …
More Releases from Transparency Market Research
Bruise Treatment Market Outlook 2031: From US$ 312.3 Million in 2021 to Over US$ …
The global Bruise Treatment Market, valued at US$ 312.3 million in 2021, is projected to grow at a compound annual growth rate (CAGR) of 3.5% from 2022 to 2031, surpassing US$ 444 million by 2031. Bruise treatment involves products like topical creams, gels, and oral supplements to reduce bruising caused by trauma, surgeries, or medical conditions. The market is driven by increasing injury incidence, growing awareness of bruise management, and…
Dental Anesthetics Market Outlook 2031: From US$ 705.5 Million in 2021 to Over U …
The global Dental Anesthetics Market, valued at US$ 705.5 million in 2021, is projected to grow at a compound annual growth rate (CAGR) of 2.6% from 2022 to 2031, surpassing US$ 904.1 million by 2031. Dental anesthetics, such as lidocaine and articaine, are used to manage pain during dental procedures like extractions, root canals, and implants. The market is driven by increasing dental procedures, growing awareness of oral health, and…
Anaphylaxis Market Forecast to 2035: USD 2.1 Billion in 2024 to USD 3.9 Billion …
The global anaphylaxis market is poised for sustained expansion, with industry valuation anticipated to rise from US$ 2.1 billion in 2024 to more than US$ 3.9 billion by the end of 2035, growing at a compound annual growth rate (CAGR) of 5.9%. Increasing prevalence of severe allergic reactions, rising awareness, and continued innovation in epinephrine delivery systems are pivotal to this market's trajectory.
Access key findings and insights from our Report…
Drug Delivery Systems Market Size Worth USD 462.9 Billion by 2035, Expanding at …
The global drug delivery systems market is undergoing a dynamic transformation as it continues to evolve with advancements in technology and increasing focus on patient-centric care. Valued at US$ 265.9 billion in 2024, the market is expected to witness robust expansion, reaching US$ 462.9 billion by 2035, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period. This growth trajectory is being strongly influenced by escalating…
More Releases for Retinal
Retinal Vein Occlusion Market : Information by Type (Branch Retinal Artery Occlu …
Retinal vein occlusion (RVO) causes permanent blindness. It is dominant in the geriatric population. However, it can also be found in people with leukemia, glaucoma, lymphoma, and multiple myeloma. Retinal vein occlusion is broadly categorized into central retinal artery occlusion (CRAO) and branch retinal vein occlusion (BRVO). Glaucoma is another such condition that damages optic nerves and causes retinal vein occlusion, which is becoming another point of concern across…
What's driving the Retinal Implants Market Growth? Prominent Players: Second Sig …
An analysis of Retinal Implants market has been provided in the latest report added by Market Study Report that primarily focuses on the market trends, demand spectrum, and future prospects of this industry over the forecast period. Furthermore, the report provides a detailed statistical overview in terms of trends outlining the geographical opportunities and contributions by prominent industry share contenders.
The global Retinal Implants market is valued at million…
Retinal Implants Sales Market Analysis By Top Players - Second Sight Medical Pro …
Worldwide Market Reports has announced the addition of the “Global Retinal Implants Market Size Status and Forecast 2022”, The report classifies the global Retinal Implants Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
Global Retinal Implants market competition by top manufacturers/players, with Retinal Implants sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player;…
Retinal Implants Sales Market Analysis By Top Players - Second Sight Medical Pro …
Worldwide Market Reports has announced the addition of the “Global Retinal Implants Market Size Status and Forecast 2022”, The report classifies the global Retinal Implants Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
Global Retinal Implants market competition by top manufacturers/players, with Retinal Implants sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player;…
Global Retinal Implants Market 2018 - Centrasight, Retinal Implant, Boston Retin …
Eminent Market Reports, recently published a detailed market research study focused on the “Retinal Implants Market” across the global, regional and country level. The report provides 360° analysis of “Retinal Implants Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Retinal Implants on…
Retinal Surgery Device Market, Global Forecast by Segments (Retinal Lasers, Vitr …
Renub Research report titled “Retinal Surgery Device Market, Global Forecast by Segments (Retinal Lasers, Vitrectomy Machines, Instruments, Tamponades, Retinal Laser Probes, Hemostasis, Light Pipes, Cryosurgery, Vitrectomy Packs, and Light source & others.) Companies (Alcon Laboratories, Inc., Carl Zeiss, Topcon Corporation, Valeant Pharmaceutical International Inc., Iridex Coporation, Ellex Medical Lasers, Escalon Medical, and Second Sight Medical Products Inc.)” studies the global retinal surgery device market. This 85 page report with 42…
